Medicare Enrolled

Dr. Sujata Yavagal, M.D.

Urogynecology and Reconstructive Pelvic Surgery (Obstetrics & Gynecology) Physician · Miami, FL
Practice pattern: Clinical Cardiology— Primarily office-based clinical cardiology
Low-engagement
8940 N KENDALL DR STE 706E, Miami, FL 33176
7865348884
In practice since 2005 (20 years)
NPI: 1962499426 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Yavagal from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Yavagal? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Yavagal

Dr. Sujata Yavagal is an urogynecology and reconstructive pelvic surgery (obstetrics & gynecology) physician in Miami, FL, with 20 years in practice. Based on federal Medicare data, Dr. Yavagal performed 3,070 Medicare services across 1,390 unique beneficiaries.

Between the years covered by Open Payments, Dr. Yavagal received a total of $6,660 from 25 pharmaceutical and/or device companies across 145 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in urogynecology and reconstructive pelvic surgery (obstetrics & gynecology) physician. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Yavagal is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years in practice▲ Top 28% volume in FL$ $6,660 industry payments

Medicare Practice Summary

Medicare Utilization ↗
3,070
Medicare services
Top 28% in FL for urogynecology and reconstructive pelvic surgery (obstetrics & gynecology) physician
1,390
Unique beneficiaries
$55
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~154 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

ProcedureVolumeAvg. paidAvg. submitted
Botox injection, per unit1,300$5$14
Office visit, established patient (20-29 min)379$72$300
Insertion of temporary bladder tube350$37$250
Office visit, established patient (30-39 min)348$105$355
Diagnostic exam of bladder and urethra using an endoscope85$193$587
Electronic assessment of bladder emptying82$7$246
Complex measurement of pressure of urine flow in bladder with urethra pressure and voiding pressure studies72$319$1,400
Non-needle measurement and recording of electrical activity of muscles at bladder and bowel openings72$27$570
Insertion of device into abdomen with pressure and urine flow rate study72$160$535
New patient office visit (45-59 min)71$130$500
Office visit, established patient (10-19 min)56$40$175
Fitting and insertion of vaginal support device32$66$209
Cervical or vaginal cancer screening; pelvic and clinical breast examination29$43$156
Pessary, non rubber, any type26$53$125
Office visit, established patient, complex (40-54 min)21$141$500
Repair of herniated rectum into vaginal wall18$326$1,875
Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional18$19$95
Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory14$45$110
Exam with injections of chemical for destruction of bladder using an endoscope13$332$1,000
Injection of implant material beneath lining of bladder and/or urethra using an endoscope12$119$837
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$6,660
Total received (2018-2024)
Avg $951/year across 7 years
Top 41% in FL for urogynecology and reconstructive pelvic surgery (obstetrics & gynecology) physician
25
Companies
145
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$6,185 (92.9%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$475 (7.1%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$358
2023
$812
2022
$427
2021
$969
2020
$175
2019
$2,694
2018
$1,224

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Coloplast Corp
$1,888
KARL STORZ Endoscopy-America
$1,541
Axonics, Inc.
$836
Astellas Pharma US Inc
$556
Mission Pharmacal Company
$316
PFIZER INC.
$246
Medtronic, Inc.
$187
Sumitomo Pharma America, Inc.
$152
UROVANT SCIENCES INC
$146
AMAG Pharmaceuticals, Inc.
$93
AbbVie Inc.
$87
ABBVIE INC.
$83
MILLICENT US INC
$82
Allergan, Inc.
$79
Allergan Inc.
$72
GE HealthCare
$57
Lupin Inc.
$41
MISSION PHARMACAL COMPANY
$36
TherapeuticsMD, Inc.
$34
MAYNE PHARMA COMMERCIAL LLC
$29
FEMSelect Inc.
$28
AbbVie, Inc.
$21
Duchesnay USA Incorporated
$19
Bayer HealthCare Pharmaceuticals Inc.
$18
Laborie Medical Technologies Corp.
$14
Top 3 companies account for 64.1% of total payments
Associated products mentioned in payments ›
ALTIS · ANNOVERA · AUTOCLAV · AXIS · Altis · Axonics · Axonics r-SNM System · BOTOX · Bulkamid · C-MAC POWER SUPPLY REPLACEMENT F/8403ZX · CCU/LIGHT SOURCE/MONITOR · CONTINENCE CARE · ENPLACE · Femring · GEMTESA · HOPKINS II · HOPKINS II FWD OBLG · IMVEXXY · INSULATED · INTERSTIM · INTRAROSA · Kyleena · LO LOESTRIN FE · MYFEMBREE · MYRBETRIQ · Myrbetriq · OUTER · Orilissa · Osphena · PREMARIN · PREMARIN ORALS · PVC · RESTORELLE · SOLOSEC · TELE PACK X LED · TELESCOPE · TUBE · URIBEL · URIBEL TABS · Uribel · VESICARE · Veozah · W/LUER-
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (93%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Equivalent to $217 per 100 Medicare services performed
Looking for a urogynecology and reconstructive pelvic surgery (obstetrics & gynecology) physician in Miami?
Compare urogynecology and reconstructive pelvic surgery (obstetrics & gynecology) physicians in the Miami area by procedure volume, costs, and industry payment transparency.
Browse urogynecology and reconstructive pelvic surgery (obstetrics & gynecology) physicians nearby

Geographic Context

Urogynecology and Reconstructive Pelvic Surgery (Obstetrics & Gynecology) Physicians within 10 mi
6
Per 100K population
0.2
County median income
$68,694
Nearest hospital
BAPTIST HOSPITAL OF MIAMI
0.0 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data Medicare Util.Annual (CY lag)
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Yavagal is a clinical cardiology specialist, with above-average Medicare volume (top 28% in FL), and low-engagement industry engagement, with 20 years of practice experience.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Yavagal experienced with botox injection, per unit?
Based on Medicare claims data, Dr. Yavagal performed 1,300 botox injection, per unit services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Yavagal receive payments from pharmaceutical companies?
Yes. Dr. Yavagal received a total of $6,660 from 25 companies across 145 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Yavagal's costs compare to other urogynecology and reconstructive pelvic surgery (obstetrics & gynecology) physicians in Miami?
Dr. Yavagal's average Medicare payment per service is $55. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Yavagal) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →